- Home
- LPCN vs SEGG Comparison
LPCN vs SEGG Comparison
Compare LPCN & SEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- SEGG
- Stock Information
- Founded
- LPCN 1997
- SEGG N/A
- Country
- LPCN United States
- SEGG United States
- Employees
- LPCN N/A
- SEGG 12
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- SEGG Computer Software: Prepackaged Software
- Sector
- LPCN Health Care
- SEGG Technology
- Exchange
- LPCN Nasdaq
- SEGG Nasdaq
- Market Cap
- LPCN 18.2M
- SEGG 14.7M
- IPO Year
- LPCN N/A
- SEGG 2023
- Fundamental
- Price
- LPCN $2.75
- SEGG $4.42
- Analyst Decision
- LPCN Strong Buy
- SEGG
- Analyst Count
- LPCN 1
- SEGG 0
- Target Price
- LPCN $8.00
- SEGG N/A
- AVG Volume (30 Days)
- LPCN 59.3K
- SEGG N/A
- Earning Date
- LPCN 11-07-2025
- SEGG N/A
- Dividend Yield
- LPCN N/A
- SEGG N/A
- EPS Growth
- LPCN N/A
- SEGG N/A
- EPS
- LPCN N/A
- SEGG N/A
- Revenue
- LPCN $4,208,119.00
- SEGG N/A
- Revenue This Year
- LPCN N/A
- SEGG N/A
- Revenue Next Year
- LPCN N/A
- SEGG N/A
- P/E Ratio
- LPCN N/A
- SEGG N/A
- Revenue Growth
- LPCN N/A
- SEGG N/A
- 52 Week Low
- LPCN $2.65
- SEGG N/A
- 52 Week High
- LPCN $6.17
- SEGG N/A
- Technical
- Relative Strength Index (RSI)
- LPCN 38.39
- SEGG 49.41
- Support Level
- LPCN $2.75
- SEGG $4.31
- Resistance Level
- LPCN $2.92
- SEGG $4.78
- Average True Range (ATR)
- LPCN 0.14
- SEGG 0.50
- MACD
- LPCN -0.04
- SEGG 0.01
- Stochastic Oscillator
- LPCN 6.12
- SEGG 56.23
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About SEGG Lottery.com Inc. Common Stock
Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.